These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 37075486)
1. Estimated number of symptomatic Lyme borreliosis cases in Germany in 2021 after adjusting for under-ascertainment. Olsen J; Angulo FJ; Pilz A; Halsby K; Kelly P; Brestrich G; Stark JH; Jodar L Public Health; 2023 Jun; 219():1-9. PubMed ID: 37075486 [TBL] [Abstract][Full Text] [Related]
2. Estimated Number of Symptomatic Lyme Borreliosis Cases in Adults in Finland in 2021 Using Seroprevalence Data to Adjust the Number of Surveillance-Reported Cases: A General Framework for Accounting for Underascertainment by Public Health Surveillance. Olsen J; Angulo FJ; Pilz A; Halsby K; Kelly P; Turunen J; Åhman H; Stark J; Jodar L Vector Borne Zoonotic Dis; 2023 Apr; 23(4):265-272. PubMed ID: 37071408 [No Abstract] [Full Text] [Related]
3. Incidence of symptomatic Lyme borreliosis in nine European countries. Angulo FJ; Colby E; Lebech AM; Lindgren PE; Moniuszko-Malinowska A; Strle F; Olsen J; Brestrich G; Vyse A; Shafquat M; Gould LH; Kelly PH; Pilz A; Halsby K; Moïsi JC; Stark JH Int J Infect Dis; 2024 Sep; 149():107242. PubMed ID: 39306075 [TBL] [Abstract][Full Text] [Related]
4. Incidence of symptomatic Borrelia burgdorferi sensu lato infection in Romania, 2018-2023. Angulo FJ; Olsen J; Purdel V; Lupșe M; Hristea A; Briciu V; Colby E; Pilz A; Halsby K; Kelly PH; Brestrich G; Moïsi JC; Stark JH Parasit Vectors; 2024 Sep; 17(1):378. PubMed ID: 39238048 [TBL] [Abstract][Full Text] [Related]
5. Estimated Incidence of Symptomatic Lyme Borreliosis Cases in Lublin, Poland in 2021. Colby E; Olsen J; Angulo FJ; Kelly P; Halsby K; Pilz A; Sot U; Chmielewski T; Pancer K; Moïsi JC; Jodar L; Stark JH Microorganisms; 2023 Oct; 11(10):. PubMed ID: 37894139 [TBL] [Abstract][Full Text] [Related]
6. Estimated incidence of symptomatic Lyme borreliosis cases in five southern coastal counties in Norway, 2022. Colby E; Molden T; Olsen J; Kelly P; Pilz A; Halsby K; Brestrich G; Angulo FJ; Moïsi JC; Stark JH APMIS; 2024 Nov; 132(11):832-842. PubMed ID: 39377522 [TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of Lyme Borreliosis in Europe: Results from a Systematic Literature Review (2005-2020). Burn L; Pilz A; Vyse A; Gutiérrez Rabá AV; Angulo FJ; Tran TMP; Fletcher MA; Gessner BD; Moïsi JC; Stark JH Vector Borne Zoonotic Dis; 2023 Apr; 23(4):195-220. PubMed ID: 37071401 [No Abstract] [Full Text] [Related]
8. Trends in surveillance data of human Lyme borreliosis from six federal states in eastern Germany, 2009-2012. Wilking H; Stark K Ticks Tick Borne Dis; 2014 Apr; 5(3):219-24. PubMed ID: 24656810 [TBL] [Abstract][Full Text] [Related]
9. The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium. Lernout T; Kabamba-Mukadi B; Saegeman V; Tré-Hardy M; de Laveleye M; Asikainen T; Dessau RB; Quoilin S; Litzroth A BMC Public Health; 2019 May; 19(1):597. PubMed ID: 31101034 [TBL] [Abstract][Full Text] [Related]
10. Incidence of Lyme Borreliosis in Europe from National Surveillance Systems (2005-2020). Burn L; Tran TMP; Pilz A; Vyse A; Fletcher MA; Angulo FJ; Gessner BD; Moïsi JC; Jodar L; Stark JH Vector Borne Zoonotic Dis; 2023 Apr; 23(4):156-171. PubMed ID: 37071405 [No Abstract] [Full Text] [Related]
11. Seropositivity of Lyme borreliosis and associated risk factors: a population-based study in Children and Adolescents in Germany (KiGGS). Dehnert M; Fingerle V; Klier C; Talaska T; Schlaud M; Krause G; Wilking H; Poggensee G PLoS One; 2012; 7(8):e41321. PubMed ID: 22905101 [TBL] [Abstract][Full Text] [Related]
13. Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area. van den Wijngaard CC; Hofhuis A; Simões M; Rood E; van Pelt W; Zeller H; Van Bortel W Euro Surveill; 2017 Jul; 22(27):. PubMed ID: 28703098 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of Borrelia IgG antibodies among young Swedish children in relation to reported tick bites, symptoms and previous treatment for Lyme borreliosis: a population-based survey. Skogman BH; Ekerfelt C; Ludvigsson J; Forsberg P Arch Dis Child; 2010 Dec; 95(12):1013-6. PubMed ID: 20702388 [TBL] [Abstract][Full Text] [Related]
15. Seroprevalence, seroconversion and seroreversion of Böhm S; Woudenberg T; Stark K; Böhmer MM; Katz K; Kuhnert R; Schlaud M; Wilking H; Fingerle V Euro Surveill; 2023 Aug; 28(34):. PubMed ID: 37616114 [TBL] [Abstract][Full Text] [Related]
16. Incidence of Lyme Borreliosis in Germany: Exploring Observed Trends Over Time Using Public Surveillance Data, 2016-2020. Skufca J; Tran TMP; Brestrich G; Pilz A; Vyse A; Malerczyk C; Dzingina M; Begier E; Blum M; Riera-Montes M; Gessner BD; Stark JH Vector Borne Zoonotic Dis; 2023 Apr; 23(4):237-246. PubMed ID: 37071399 [No Abstract] [Full Text] [Related]
17. Seroprevalence of Lyme borreliosis in Finland 50 years ago. Cuellar J; Dub T; Sane J; Hytönen J Clin Microbiol Infect; 2020 May; 26(5):632-636. PubMed ID: 31622667 [TBL] [Abstract][Full Text] [Related]
18. Seropositivity of Borrelia burgdorferi in a cohort of symptomatic cats from Europe based on a C6-peptide assay with discussion of implications in disease aetiology. Pantchev N; Vrhovec MG; Pluta S; Straubinger RK Berl Munch Tierarztl Wochenschr; 2016; 129(7-8):333-9. PubMed ID: 27529996 [TBL] [Abstract][Full Text] [Related]
19. Epidemiology of Lyme borreliosis based on outpatient claims data of all people with statutory health insurance, Germany, 2019. Akmatov MK; Holstiege J; Dammertz L; Heuer J; Kohring C; Lotto-Batista M; Boeing F; Ghozzi S; Castell S; Bätzing J Euro Surveill; 2022 Aug; 27(32):. PubMed ID: 35959689 [TBL] [Abstract][Full Text] [Related]
20. The Incidence of Lyme Borreliosis Among Children. Shafquat M; Angulo FJ; Pilz A; Moïsi JC; Stark JH Pediatr Infect Dis J; 2023 Oct; 42(10):867-874. PubMed ID: 37406218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]